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OBJECTIVES The role of atrial myocytes and extracellular matrix (ECM) changes in atrial chamber
remodeling was studied in a canine model of heart failure (HF).
BACKGROUND Cardiac remodeling is a key process mediating the progression of HF. Studies of the
structural mechanisms of cardiac remodeling have been limited to the left ventricle. The
structural alterations associated with atrial chamber remodeling in evolving HF have not been
studied.
METHODS Age- and weight-matched dogs were subjected to right ventricular pacing (240 beats/min) for
one and three weeks to produce early and severe HF, respectively. Atrial tissues were assessed
for myocyte and ECM changes.
RESULTS Right atrial and left atrial (LA) pressures were significantly increased in early and severe HF.
The LA wall tension index was significantly increased at both HF stages by 116% and 443%,
respectively. Atrial collagen synthesis and degradation were significantly increased in severe
HF. Gelatinase activity was significantly increased at both early and severe stages of HF.
Gelatin zymography showed increased matrix metalloproteinases (MMP)-9 with early HF
and increased MMP-2 with severe HF. The LA wall tension index was significantly
correlated with gelatinase activity and collagen synthesis. Although total atrial collagen
content was not changed, disarray of collagen fibers was observed. Atrial myocyte hypertrophy
without evidence of apoptosis was also present in severe HF.
CONCLUSIONS There is marked atrial chamber remodeling in canine pacing-induced HF, which is
characterized by myocyte hypertrophy and dynamic collagen turnover. Atrial remodeling may
contribute to the development of atrial arrhythmias and pulmonary hypertension and could
offer a novel therapeutic target. (J Am Coll Cardiol 2004;43:68–76) © 2004 by the
American College of Cardiology Foundation
Although the etiologies of chronic heart failure (HF) may
be diverse, a crucial process in the progression of most forms
of HF is left ventricular (LV) remodeling. The process of
LV remodeling involves changes in both myocyte and
extracellular matrix (ECM), including the activation of
proteolytic enzymes and alteration in the myocardial colla-
gen organization. These, in turn, lead to alterations in LV
chamber geometry and function (1–4).The atrial chambers
may also undergo significant geometric remodeling (cham-
ber remodeling) during evolving HF (5–7). Left atrial (LA)
volume has been shown to be significantly associated with
LV chamber remodeling, diastolic dysfunction, and the
degree of mitral regurgitation in patients with dilated
cardiomyopathy (7). However, unlike the LV, the structural
basis for atrial chamber remodeling process in HF has not
been characterized. We hypothesized that atrial chamber
remodeling in HF is accompanied by changes in both the
atrial myocytes and the ECM. Accordingly, the objectives
of the current study were to characterize the cellular and
ECM changes in relation to chamber remodeling in the
atria during evolving HF. To achieve this goal, we employed
a canine model of pacing-induced HF that induces signif-
icant LV chamber remodeling, contractile dysfunction,
neurohormonal activation, and a phenotype of HF that
closely mimics human dilated cardiomyopathy (6,8) and is
accompanied by significant biatrial chamber remodeling
(5,6,9).
METHODS
Experimental preparation. Age- and weight-matched
male dogs were divided into four groups. Eight dogs
underwent continuous rapid right ventricular pacing (240
beats/min) for one week and were designated as the group
with early HF. A second group of eight dogs was paced for
three weeks and designated as the group with severe HF.
Because one- and three-week paced dogs were studied at
different times to eliminate time-dependent biases, two
groups of non-paced normal dogs (n  5 for the one-week
paced dogs, n  10 for the three-week paced dogs) served
as controls. Animal experiments were performed in accor-
dance with the guidelines, “Care and Use of Experimental
Animals,” issued by the Canadian Council on Animal Care,
Ottawa, Canada.
The method of induction of HF and the clinical, radio-
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graphic, hemodynamic, and echocardiographic assessments
have been described in detail previously (6,8,10). In the
paced dogs, hemodynamic and echocardiographic data were
obtained after the pacer was reprogrammed off to resume
sinus rhythm for at least 20 min. Two-dimensional echo-
cardiography was performed weekly to monitor changes in
LV ejection fraction and to ensure the development of LV
systolic dysfunction. Images were recorded on half-inch
videotape and analyzed off-line. Echocardiographically de-
rived indexes of LV dimensions were calculated using
standard formulas as described previously (10). Left atrial
cross-sectional areas were obtained at the plane of aortic
valve incorporating area defined by both the LA free wall
and the appendage. A radius for the LA was derived from
the cross-sectional area assuming a circular shape of the
chamber (5,9). The product of pulmonary capillary wedge
pressure and the radius were used as indexes of LA wall
tension (5,9). Due to a difficult echocardiographic window,
measurements of right atrial (RA) area were not possible.
Hemodynamic measurements were obtained at baseline to
ensure normality and repeated before sacrifice, using a
micromanometer-tipped catheter introduced via the femoral
artery and a thermodilution catheter introduced via the
femoral vein. At the end of the in vivo study, the chest was
opened under sodium thiopental anesthesia, and the heart
arrested with potassium chloride. The heart was removed
and rinsed in cold saline. Left atrium and RA samples were
taken for biochemical and histological analysis. Additional
samples for measuring matrix metalloproteinase (MMP)
activity were snap frozen in liquid N2 and stored at 80°C
until use.
Histology. Tissue samples were randomly taken from the
atrial free wall, and 5-m-thick sections were stained with
hematoxylin and eosin for cellular morphology and picro-
sirius red for collagen. Computerized morphometry (Scion
Image, Frederick, Maryland) was used to determine the
myocyte number and area per high power field (hpf).
Measurements were done in at least three randomly selected
hpf in each atria.
Collagen synthesis and content. Collagen synthesis and
content in atrial tissues were measured using a previously
described method (11). In brief, the tissues were incubated
in Dulbecco’s modified eagle medium containing 1% fetal
calf serum, 14C-proline (0.5 Ci/ml, Amersham Bio-
sciences, Piscataway, New Jersey), and ascorbic acid (50
g/ml) for 6 h at 37°C. The samples were then digested
overnight in cyanogen bromide, which solubilizes proteins
by cleaving methionine amino acid bonds, with the excep-
tion of elastin, which contains no methionine. For collagen
synthesis, 14C-hydroxyproline incorporation was measured
and expressed as counts per min/mg tissue. For collagen
content, hydroxproline was measured and expressed as g
hydroxyproline/mg tissue.
Western blot analysis for collagen fragments and caspase-3.
Atrial extracts were fractionated on 4% to 12 % tris-glycine
gels under reducing or nonreducing conditions for collagen
fragments and caspase-3, respectively. Fractionated proteins
were electroblotted onto nitrocellulose membranes. For
collagen fragments, the membrane was immunoblotted with
rabbit polyclonal primary anti-COL2 three-quarters C (di-
lution 1:1000, HDM Diagnostics & Imaging Inc., Toronto,
Ontario, Canada) that specifically recognizes -chain frag-
ments of collagen containing approximately 8 amino acid
sequences on carboxy terminus. For caspase-3, the mem-
brane was immunoblotted with rabbit polyclonal anti-
caspase-3 (CPP32) Ab-4 (NeoMarker, Fremont, Califor-
nia). Anti rabbit IgG-HRP (Santa Cruz Biotechnology,
Santa Cruz, California) was used for detection of primary
antibody. Detection was performed using enhanced chemi-
luminescence (Amersham ECL Plus).
Gelatinase activity assays. Zymography was performed as
previously described (11,12). The clear gelatinolytic zones
were quantified by densitometric analysis using the Molec-
ular Analyst Software (Bio-RAD, Hercules, California).
Table 1. In Vivo Hemodynamic Parameters
Early HF Severe HF
HF Control HF Control
RAP, mm Hg 6.2  1.0* 2.8  0.8 12.9  0.6†‡ 2.7  0.7
PCWP, mm Hg 14.8  1.0* 7.0  0.3 32.1  2.1†‡ 8.1  0.8
CO, l/min 2.6  0.3* 3.9  0.1 2.1  0.2†‡ 4.0  0.3
LA wall tension, U 2.2  0.1* 1.0  0.1 3.4  0.5†‡ 0.7  0.1
Data are expressed as mean  SEM. *p  0.05; †p  0.01 vs. respective controls; ‡p  0.05 severe vs. early HF.
CO  cardiac output; HF  heart failure; LA  left atrium; PCWP  pulmonary capillary wedge pressure; RAP  right
atrial pressure.
Abbreviations and Acronyms
ACE  angiotensin converting enzyme
ECM  extracellular matrix
HF  heart failure
hpf  high power field
LA  left atrial/atrium
LV  left ventricle/ventricular
MMP  matrix metalloproteinases
mRNA  messenger RNA
TIMP  tissue inhibitor of metalloproteinases
RA  right atrial/atrium
TUNEL  terminal deoxy nucleotidyl transferase (TdT)-
mediated dUTP-biotin nick-end labeling
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Gelatinase activity was also measured quantitatively using a
gelatin-fluorescein conjugate substrate (EnzChek gelatinase
assay, Molecular Probes, Eugene, Oregon) as reported by us
previously (12). To confirm the specificity of this assay,
samples were incubated with gelatin substrate in the pres-
ence of 20 mM GM6001 (MMP inhibitor), 1 mM elafin
(serine elastase inhibitor), and 5 mM iodacetamide (cysteine
protease inhibitor).
Terminal deoxy nucleotidyl transferase-mediated dUTP-
biotin nick-end labelling (TUNEL). Apoptotic cells were
identified in 5-m-thick sections by TUNEL assay using a
commercially available kit (ApopTag, Intergen, New York).
Statistical analysis. All data are presented as mean 
SEM. Statistical comparison between the control and paced
groups was done by unpaired Student t test. Because the
one-week paced series and three-week paced series were
studied at different times, no attempt was made to compare
the one-week and the three-week paced dogs. Correlations
between changes in wall tension, gelatinase activity, and
collagen synthesis in three-week paced LA were made using
linear regression analysis by least square fit method. Statis-
tical significance was set at p  0.05.
RESULTS
In vivo hemodynamic and echocardiographic data. The
development of HF in the paced dogs was confirmed by
clinical, radiographic, and hemodynamic assessments. In
control dogs and one-week paced dogs (early HF), clinical
signs of HF were absent. All three-week paced dogs
developed severe HF based on the presence of at least two
of the three clinical signs of HF (apathy, anorexia, and
ascites) and radiographic evidence of pulmonary edema
and cardiomegaly. The hemodynamic, echocardiographic,
and post-mortem data are shown in Tables 1 and 2. Data of
the control groups of normal dogs for the one-week paced
and the three-week paced dogs were very similar. With early
HF, there was a modest increase in RA and LA pressure,
accompanied by a decline in cardiac output. With severe
HF, RA and LA pressures and LV end-diastolic pressure
were markedly elevated, with significant decline in cardiac
output. Echocardiographic analysis showed progressive
increase in LV end-diastolic volume. The LV chamber dilation
was accompanied by a progressive increase in LA cross-
sectional area. Left atrium wall tension index also progressively
increased during evolving HF. Compared with the controls,
LA wall tension with early and severe HF was greater by 116%
and 443%, respectively. Post-mortem LA and RA weights
were also increased significantly compared with the respective
controls at both early and severe stages of HF, signifying the
development of significant atrial hypertrophy.
Collagen synthesis and content. Atrial collagen synthesis
was increased significantly in severe HF compared with
controls (Table 3). However, collagen content in both atria
did not differ from the controls.
Collagen degradation. Collagen fragments were signifi-
cantly greater in both atria with severe HF compared with
the controls (Fig. 1, data for LA not shown).
Gelatinase activity. Both pro- and active forms of
MMP-9 activity were increased in LA during early HF
compared with controls, whereas MMP-2 remained essen-
tially unchanged (Fig. 2). With severe HF, both pro- and
active forms of MMP-2 were significantly increased,
whereas no differences were observed in MMP-9 activity.
Table 2. In Vivo Echocardiographic and Post-Mortem Parameters
Early HF Severe HF
HF Control HF Control
Echocardiographic
LAA, m2/kg 1.6  0.3 1.1  0.1 4.5  0.3†‡ 1.8  0.2
LVEDV, ml/kg 3.8  0.2* 3.0  0.2 4.5  0.2†‡ 2.8  0.2
Post-mortem
LA weight, mg/kg 0.16  0.01* 0.09  0.01 0.20  0.01† 0.09  0.01
RA weight, mg/kg 0.14  0.01* 0.08  0.02 0.18  0.02† 0.07  0.01
Data are expressed as mean  SEM. *p  0.05; †p  0.01 vs. respective controls; ‡p  0.05 severe vs. early HF.
HF  heart failure; LA  left atrium; LAA  left atrial cross-sectional area; LVEDV  left ventricular end-diastolic
volume; RA  right atrium.
Table 3. Collagen Content and Synthesis
Control Severe HF
Collagen content (g OH proline/mg tissue)
LA 9.6  0.8 11.7  1.2
RA 8.1  0.7 9.9  1.0
Collagen synthesis (14C-OH proline/mg tissue)
LA 6.0  0.8 9.5  1.4*
RA 4.9  1.0 9.0  1.3*
Data are expressed as mean  SEM. *p  0.05 vs. control.
HF  heart failure; LA  left atrium; RA  right atrium.
70 Khan et al. JACC Vol. 43, No. 1, 2004
Atrial Remodeling in Heart Failure January 7, 2004:68–76
Similar results were observed in the RA (results not shown).
In the fluorescence assay, higher levels of gelatinase activity
were present in LA at both stages of HF compared with
their respective controls (Fig. 3A). There was complete
inhibition of gelatinolytic activity by GM6001, indicating
that MMPs were responsible for the gelatinolytic activity
(Fig. 3B).
Atrial myocytes. At severe HF, the atria showed marked
myocyte hypertrophy compared with controls (Fig. 4).
Bundles of myofibrils were less tightly packed than in
controls, and the number of myocytes/hpf was significantly
reduced in severe HF, signifying hypertrophy at the myo-
cyte level (Table 4).
Fibrosis. Picrosirius staining showed increased endocardial
and interstitial fibrosis in both the RA and LA with severe
HF (Fig. 5). The interstitial fibrosis was diffuse and patchy
in some areas, and muscle necrosis could be seen around
areas of intense fibrosis. In contrast, the atria of control
hearts contained well-organized collagen bundles inter-
spersed between atrial myocytes.
Apoptosis. There were no significant differences in
TUNEL staining in the atria of controls, or at both stages
of HF (Fig. 6). There was no evidence of active caspase-3 in
control or HF atria, indicating absence of apoptosis (data
not shown).
Relationship between pulmonary hemodynamics, atrial
wall tension index, and atrial collagen turnover in severe
HF. There was a significant correlation between mean
pulmonary artery pressure and gelatinase activity (Fig. 7A).
In addition, there were also significant correlations between
the changes in LA wall tension index and the two indicators
of collagen turnover, collagen synthesis, and gelatinase
activity (Figs. 7B and 7C).
DISCUSSION
Although ventricular remodeling has been described exten-
sively in various models of HF, the biochemical and
structural changes that characterize atrial chamber remod-
eling in HF have not been studied. The principal findings of
our study are: 1) significant atrial chamber remodeling
occurs during evolving HF, 2) this geometric remodeling is
Figure 1. (Upper panel) Representative Western blot for degraded colla-
gen in an right atrium with severe heart failure (HF). Lanes 1 to 4 are
controls. Lanes 5 to 8 are severe HF. (Lower panel) Group data from
densitometric analysis. *p  0.01 versus control.
Figure 2. Gelatin zymograms of gelatinase activity in the left atrium of control and heart failure (HF) animals. (Upper panels) Early HF. (Lower panels)
Severe HF. On the left panels, lanes 1 to 4 represent controls, and lanes 5 to 8 are HF. In early HF, pro- and active matrix metalloproteinases (MMP)-9
are increased, while MMP-2 activity is not significantly changed. In severe HF, pro- and active MMP-2 are significantly increased, while MMP-9 activity
is not significantly changed. The corresponding densitometry is shown in the right panels. *p  0.05 versus respective controls.
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accompanied by atrial myocyte hypertrophy and active
collagen turnover, and 3) the perturbations in pulmonary
hemodynamics and atrial wall tension are closely correlated
to indexes of atrial collagen turnover.
Atrial chamber remodeling. The canine pacing model
demonstrates progressive increase in LA chamber dimen-
sions with marked increases in the post-mortem weights in
both atria. These findings are consistent with our previous
sequential observations of atrial dimensions (5,6,9,10) and
post-mortem measurements of atrial weight (8,13). The
atrial myocytes and the collagen matrix are both involved in
these progressive remodeling changes.
Atrial myocytes. Our study indicates a marked increase in
the cross-sectional areas of the atrial myocytes in HF which
have been previously observed in this model (9). Atrial
myocyte hypertrophy, along with the absence of detectable
apoptosis, contributes to the increased chamber weight and,
therefore, constitutes one of the mechanisms for atrial
remodeling. The increase in myocyte area, coupled with
increased fibrosis, may account for the reduced number of
myocytes observed per hpf. The factors leading to myocyte
hypertrophy in the atria are probably similar to those in the
ventricle, namely mechanical stretch with the attendant
stretch-activated pathways, and the elaboration of various
growth factors and cytokines such as angiotensin II,
endothelin-1, insulin growth factor-1, interleukin-6, and
gp130 (14–18). Our results are consistent with a goat model
of sustained atrial fibrillation, which also had markedly
increased atrial pressures and myocyte hypertrophy without
evidence of atrial myocyte apoptosis (19,20). The lack of
detectable apoptosis in the atrium is in contrast with the
marked increase in myocyte apoptosis in paced failing
canine ventricles (19–23), and, thus, represents a uniquely
different mechanism of remodeling in the atria.
Collagen turnover. Increased turnover of collagen, the
principal ECM protein in the atria, constitutes the second
Figure 3. (A) Quantitative gelatinase assay. (Left panels) Comparison between early heart failure (HF) and respective controls. (Right panels) Comparison
between severe HF and respective controls. (Upper panels) Left atrium (LA). (Lower panels) Right atrium (RA). *p  0.01 versus respective controls;
†p  0.05 versus control. (B) Effect of protease inhibition on gelatinase activity. Data are means of triplicate assays. There is 100% inhibition of gelatinase
activity with GM6001, an matrix metalloproteinases inhibitor.
72 Khan et al. JACC Vol. 43, No. 1, 2004
Atrial Remodeling in Heart Failure January 7, 2004:68–76
mechanism mediating atrial chamber remodeling. The si-
multaneous increase in both collagen synthesis and markers
of collagen degradation indicate a dynamic turnover of the
collagen matrix in the atria. Active collagen turnover has
been previously reported in the volume-overloaded ventricle
leading to the onset of chamber dilation (24). In this study,
collagen turnover and alterations in collagen organization in
the atria were strongly correlated with LA wall tension
index, suggesting a role for hemodynamic load in mediating
these atrial ECM changes. These effects may be mediated
by angiotensin-II, which is increased both locally in the atria
and systemically in HF (25,26). Indeed, infusion of
angiotensin-II to rats causes marked fibrosis of both atria
(27). In the human atria, a strong correlation between
collagen I messenger RNA (mRNA) and angiotensin-
converting enzyme (ACE) mRNA has also been observed
(28). Moreover, treatment with the ACE inhibitor enalapril
in this canine model significantly reduced atrial angiotensin-II
levels and fibrosis as measured by collagen volume fraction
(25).
Our results also indicate increased atrial gelatinolytic
activity, even in dogs with early HF when the hemodynamic
perturbations are modest. This suggests that remodeling of
the ECM may be one of the mechanisms for increased atrial
dimension observed in early HF, whereas deteriorating
hemodynamics and fluid retention contribute to further
increases in atrial size with severe HF. Among the different
MMPs that have been identified, MMP-2 and MMP-9,
the gelatinases, have been most frequently reported to be
increased in the remodeled or failing ventricle (29). Factors
known to induce the expression of MMPs in various cell
systems include catecholamines, angiotensin II, and endo-
thelin (30–33), which are markedly activated in pacing-
induced HF (6). In addition, increased hemodynamic load
per se may influence the expression of MMPs, at least in the
ventricular myocardium (34). Thus, increased atrial wall
tension may be another stimulus for increased MMP
activity, which is supported by the correlation between LA
wall tension index and gelatinase activity in our study.
Our study also indicates a unique temporal profile of
MMP activation in the atria with predominantly MMP-9
activity in early HF, followed by MMP-2 activity in severe
HF. In the end-stage human failing ventricle, increases in
both MMP-2 and MMP-9 activity have been observed
(1,35,36). In this canine HF model, we have recently
reported a marked increase in MMP-9 and MMP-13
(interstitial collagenase) in the advanced failing ventricle
(37). However, relative myocardial MMP-2 level was un-
changed. Therefore, it appears that there is an opposite
pattern of MMP-2 and MMP-9 activation in the atrium
compared with the ventricle in evolving HF. The reasons
for this differential temporal regulation of MMP activity are
unclear. Indeed, the pattern of atrial gelatinase activity in
HF is similar to the arterial wall after vascular injury, with
early MMP-9 activation followed by MMP-2 activation
(38).
Figure 4. Representative photomicrographs of myocytes in left atrium and right atrium stained with H & E stain (20). The nuclei stain blue and the
cytoplasm red. HF  heart failure.
Table 4. Atrial Myocyte Morphometry
Control Severe HF
Myocyte area (m2)
LA 136  13 278  33†
RA 198  33 321  35*
Myocyte number/hpf
LA 29  3 19  1†
RA 17  2 10  1*
Data are expressed as mean  SEM. *p  0.05; †p  0.01 vs. control.
HF  heart failure; LA  left atrium; RA  right atrium.
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Extracellular matrix changes occurring in pacing-induced
atrial remodeling have been reported previously (9,39). In a
dog model of atrial pacing, MMP-9 activity in the LA was
increased by 50%, while tissue inhibitor of metalloprotein-
ases (TIMP)-4 protein was decreased by a similar degree
(39). Comparison of their study with our current findings,
however, is confounded by the fact that their study utilized
atrial pacing and only assessed the changes in MMPs and
TIMPs at a single time point. In another study that used a
ventricular pacing protocol that was similar to ours, LA
collagen volume fraction, hydroxyproline, and myocyte
cross-sectional area were increased (9).
This study though did not assess serial changes over time,
or measurements of collagen synthesis or degradation. A
novel finding in our study is that increased atrial collagen
turnover in HF was not associated with a significant change
in total collagen content, but rather with a marked alteration
in collagen organization, with rearrangement of collagen
Figure 5. Representative photomicrographs of left atrium and right atrium stained with picrosirius red (20). Collagen fibers stain deep red. HF  heart
failure.
Figure 6. Representative photomicrographs of terminal deoxy nucleotidyl transferase (TdT)-mediated dUTP-biotin nick-end labeling assay. The green
stain overlapping red nuclei (arrows) indicates apoptotic nuclei. HF  heart failure.
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fibers in the atrial interstitium along with patchy deposition
of collagen. A similar pattern of collagen rearrangement is
also an important remodeling mechanism in the failing
ventricle in the pacing model (1,40).
Physiological and clinical relevance. Our study provides
for the first time a link between alterations in atrial myocytes
and the collagen matrix, and atrial chamber remodeling.
Indexes of collagen turnover (i.e., gelatinase activity and
collagen synthesis) are strongly and significantly correlated
with alterations in both pulmonary arterial pressure and LV
wall tension index. These structural changes in evolving
heart failure also have important clinical relevance. First,
collagen rearrangement and cellular hypertrophy likely me-
diate the reported alterations in atrial compliance and
function (39,41), which, in turn, contribute to the perturbed
pulmonary hemodynamics. Second, the fibrotic changes in
the interstitium may constitute a key substrate for the
development of atrial arrhythmias. Indeed, increased atrial
tissue mass can support multiple re-entry circuits (42),
predisposing to atrial arrhythmias such as atrial fibrillation.
In summary, our current data have shown that the atria
are chambers of dynamic cellular and ECM remodeling.
Marked atrial chamber dilation and elevated pressures are
associated with intense collagen turnover. The relationship
between LA wall tension unit and collagen turnover provide
circumstantial evidence that the described changes in the
atrial myocytes and interstium are a crucial response in
evolving HF, and may serve as potential therapeutic targets.
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